Gunnar Folprecht, MD, University hospital Carl Gustav Carus, University Cancer Center, Dresden, Germany:
Decoding the Paradigm Shift in mCRC Treatment—From "Selecting the Right Drug" to "Optimizing Therapeutic Sequencing"!
Exploring the New Standard of Clinical Decision-Making via Dynamic ctDNA Monitoring, and envisioning the Future of AI-Integrated Personalized Therapy.